Union Bancaire Privee UBP SA Buys Shares of 1,583 Nutrien Ltd. (NYSE:NTR)

Union Bancaire Privee UBP SA purchased a new stake in shares of Nutrien Ltd. (NYSE:NTRFree Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 1,583 shares of the company’s stock, valued at approximately $67,000.

Several other hedge funds also recently added to or reduced their stakes in NTR. Central Pacific Bank Trust Division acquired a new position in Nutrien in the 3rd quarter valued at about $28,000. Exchange Traded Concepts LLC lifted its holdings in Nutrien by 96.7% during the 4th quarter. Exchange Traded Concepts LLC now owns 846 shares of the company’s stock worth $38,000 after buying an additional 416 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Nutrien during the 2nd quarter worth approximately $52,000. Larson Financial Group LLC grew its stake in shares of Nutrien by 1,370.6% in the third quarter. Larson Financial Group LLC now owns 1,603 shares of the company’s stock worth $77,000 after acquiring an additional 1,494 shares in the last quarter. Finally, Cromwell Holdings LLC raised its stake in shares of Nutrien by 113.4% in the third quarter. Cromwell Holdings LLC now owns 1,694 shares of the company’s stock valued at $82,000 after acquiring an additional 900 shares in the last quarter. 63.10% of the stock is currently owned by hedge funds and other institutional investors.

Nutrien Price Performance

Shares of NYSE NTR opened at $53.04 on Thursday. The company’s fifty day moving average is $47.88 and its two-hundred day moving average is $48.02. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27. The firm has a market capitalization of $26.05 billion, a P/E ratio of 35.60, a PEG ratio of 1.17 and a beta of 0.81. Nutrien Ltd. has a one year low of $43.69 and a one year high of $60.87.

Nutrien (NYSE:NTRGet Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.04). Nutrien had a net margin of 2.79% and a return on equity of 6.99%. The company had revenue of $5.35 billion for the quarter, compared to analyst estimates of $5.26 billion. During the same quarter in the previous year, the business posted $0.35 earnings per share. Nutrien’s revenue was down 5.0% on a year-over-year basis. Analysts forecast that Nutrien Ltd. will post 3.5 EPS for the current fiscal year.

Nutrien Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 17th. Stockholders of record on Tuesday, December 31st were paid a dividend of $0.939 per share. This represents a $3.76 annualized dividend and a dividend yield of 7.08%. The ex-dividend date was Tuesday, December 31st. This is an increase from Nutrien’s previous quarterly dividend of $0.54. Nutrien’s payout ratio is 144.97%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the company. UBS Group boosted their price objective on Nutrien from $51.00 to $53.00 and gave the stock a “neutral” rating in a research report on Tuesday. Oppenheimer began coverage on shares of Nutrien in a report on Thursday, December 12th. They issued an “outperform” rating and a $60.00 price objective on the stock. Piper Sandler boosted their target price on shares of Nutrien from $58.00 to $63.00 and gave the stock an “overweight” rating in a research note on Monday. Barclays reaffirmed an “equal weight” rating and set a $56.00 price target (up from $55.00) on shares of Nutrien in a report on Tuesday, January 21st. Finally, TD Securities dropped their price objective on Nutrien from $63.00 to $61.00 and set a “buy” rating on the stock in a report on Tuesday, November 12th. One analyst has rated the stock with a sell rating, six have given a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Nutrien currently has an average rating of “Moderate Buy” and a consensus target price of $58.94.

View Our Latest Stock Report on NTR

Nutrien Company Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

See Also

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.